Multiplikator Forward P/S: IRADIMED (IRMD)
IRADIMED CORPORATION (IRMD) relies on global sales of MRI-compatible pumps and stable revenue from consumables. The company's unique equipment engineering for magnetic fields ensures a monopoly status, while patent protection and FDA regulations create insurmountable barriers for competitors. The change in the projected P/S ratio demonstrates the current market valuation of revenue, with the latest mark standing at 9.30.
Ringkesan rincian data analitis IRADIMED Inc. (IRMD)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal IRADIMED CORPORATION|IRMD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal IRADIMED CORPORATION|IRMD - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku IRADIMED Inc.|IRMD - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan IRADIMED|Rasio cepet iradimed.com
- rincian asil keuangan lan kelipatan valuasi:
IRMD - Penghasilan resik perusahaan|Bathi sing dikarepake IRADIMED CORPORATION|IRMD - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Iradimed|IRMD - Pangali PEG|Pangali EV/EBITDA IRADIMED Inc.|IRMD - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan IRADIMED|IRMD - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan iradimed.com|IRMD - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep IRADIMED CORPORATION
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:IRMD (IRADIMED)
The market assesses the potential of IRADIMED CORPORATION (IRMD) through the lens of expected revenue growth. This multiple relates current market capitalization to projected sales volume, determining the extent of the premium paid for future cash flows. By analyzing the forward P/S ratio, an investor can see how the stability of revenues from MRI pump consumables impacts the business valuation. Diversification of sales ensures this ratio remains resilient to local budgetary fluctuations.
Karo sapa IRADIMED CORPORATION saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|Embecta Health - Rega forward marang dodolan|TNDM (Tandem Diabetes Care) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep axogeninc.com AXGN|Rasio rega marang prakiraan pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Prakiraan rega marang pendapatan|Bioventus Corp - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake blade.com SRTA|Carlsmed (CARL) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RXST (RxSight Inc)|Rasio rega marang prakiraan pendapatan ClearPoint Neuro Inc.|Multiplikator forward rega marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|VANI: Multiplikator Forward P/S|XTNT - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan NeuroOne Medical Technologies Corporation|MODD: Rega forward marang dodolan|Multiplikator Forward P/S MYO|Multiplikator Forward P/S Envoy Medical Inc (COCH)|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|NVNO: Kapitalisasi marang prakiraan pendapatan|SINTX Technologies - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Tenon Medical Inc. TNON|ReWalk Robotics Ltd (LFWD) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Autonomix Medical|IVF (INVO Fertility Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep bonebiologics.com BBLG|Multiplikator Forward P/S AXNX|BIOLASE Inc. - Kapitalisasi marang prakiraan pendapatan|Dynatronics - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan FNA|INVO Bio - Multiplikator Forward P/S
